Impact of atrial fibrillation and anticoagulation on the risk of death, thromboembolic disease and bleeding in patients with COVID-19: the ACO-VID Registry

References

• Cattaneo M, Bertinato EM, Birocchi S, et al. Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified? Thromb Haemost. 2020;120(8):1230–1232.
   PubMed Web of Science ®Google Scholar
• Dolkar T, Patel MJ, Jitidhar F, et al. Acute COVID-19-associated cardiac arrhythmia: a case series and literature review. Cureus. 2022;14(8):e27583.
   PubMedGoogle Scholar
• World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-51. 2020. Available from: https://apps.who.int/iris/handle/10665/331475
   Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242.
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666–1687.
   PubMed Web of Science ®Google Scholar
• Axelerad A, Stuparu AZ, Muja LF, et al. Narrative review of new insight into the influence of the COVID-19 pandemic on cardiovascular care. Medicina. 2022;58(11):1554.
   PubMed Web of Science ®Google Scholar
• Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746–2751.
   PubMed Web of Science ®Google Scholar
• Krepostman N, Kramer HJ. Anticoagulation for stroke prevention in atrial fibrillation. Am J Kidney Dis. 2022;80(5):561–563.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the european association of cardio-thoracic surgery (EACTS). Eur Heart J. 2021;42(5):373–498.
   PubMed Web of Science ®Google Scholar
• Romiti GF, Corica B, Lip GYH, et al. Prevalence and impact of atrial fibrillation in hospitalized patients with COVID-19: a systematic review and meta-analysis. JCM. 2021;10(11):2490.
   Web of Science ®Google Scholar
• Li Z, Shao W, Zhang J, et al. Prevalence of atrial fibrillation and associated mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis. Front Cardiovasc Med. 2021;8:720129.
   PubMed Web of Science ®Google Scholar
• Maloberti A, Giannattasio C, Rebora P, et al. Incident atrial fibrillation and in-hospital mortality in SARS-CoV-2 patients. Biomedicines. 2022;10(8):1940.
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhao N, Du Y. Comprehensive bioinformatics analysis reveals common potential mechanisms, progression markers, and immune cells of coronary virus disease 2019 and atrial fibrillation. Front Cardiovasc Med. 2022;9:1027026.
   PubMed Web of Science ®Google Scholar
• Pardo Sanz A, Salido Tahoces L, Ortega Pérez R, et al. New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis. Cardiol J. 2021;28(1):34–40.
   PubMed Web of Science ®Google Scholar
• Kassis N, Kumar A, Gangidi S, et al. Prognostic value of initial electrocardiography in predicting long-term all-cause mortality in COVID-19. J Electrocardiol. 2022;75:1–9.
   PubMed Web of Science ®Google Scholar
• Russo V, Rago A, Carbone A, et al. Atrial fibrillation in COVID-19: from epidemiological association to pharmacological implications. J Cardiovasc Pharmacol. 2020;76(2):138–145.
   PubMed Web of Science ®Google Scholar
• Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17(9):1439–1444.
   PubMed Web of Science ®Google Scholar
• Gopinathannair R, Merchant FM, Lakkireddy DR, et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020;59(2):329–336.
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–272.
   PubMed Web of Science ®Google Scholar
• Pisters R, Lane DA, Nieuwlaat R, et al. A novel user friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey. Chest. 2010;138(5):1093–1100.
   PubMed Web of Science ®Google Scholar
• Schulman S, Kearon C. Definition of major bleeding in clinical investigations of ant hemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–694.
   PubMed Web of Science ®Google Scholar
• Magnocavallo M, Vetta G, Della Rocca DG, et al. Prevalence, management, and outcome of atrial fibrillation and other supraventricular arrhythmias in COVID-19 patients. Card Electrophysiol Clin. 2022;14(1):1–9.
   PubMedGoogle Scholar
• Stone E, Kiat H, McLachlan CS. Atrial fibrillation in COVID-19: a review of possible mechanisms. Faseb J. 2020;34(9):11347–11354.
   PubMed Web of Science ®Google Scholar
• Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–1776.
   PubMed Web of Science ®Google Scholar
• Kerolos MM, Ruge M, Gill A, et al. Clinical outcomes of COVID-19 infection in patients with pre-existing cardiovascular disease. Am Heart J Plus. 2022;20:100189.
   PubMedGoogle Scholar
• Sano T, Matsumoto S, Ikeda T, et al. New-onset atrial fibrillation in patients with coronavirus disease 2019 (COVID-19) and cardiovascular disease-insights from the CLAVIS-COVID registry. Circ J. 2022;86(8):1237–1244.
   PubMed Web of Science ®Google Scholar
• Bistrovic P, Sabljic A, Kovacevic I, et al. Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients – a retrospective cohort study on 5392 patients from a tertiary centre. Int J Cardiol. 2023;372:144–149.
   PubMed Web of Science ®Google Scholar
• Llisterri Caro JL, Cinza-Sanjurjo S, Polo Garcia J, et al. Use of direct-acting oral anticoagulants in primary care in Spain. Positioning statement by SEMERGEN on the current situation. Semergen. 2019;45(6):413–429.
   PubMedGoogle Scholar
• Díaz-Guzmán J, Freixa-Pamias R, García-Alegría J, et al. Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018. Rev Esp Cardiol (Engl Ed). 2022;75(6):496–505.
   PubMed Web of Science ®Google Scholar
• Rivera-Izquierdo M, Valero-Ubierna MDC, Martínez-Diz S, et al. Clinical factors, preventive behaviours and temporal outcomes associated with COVID-19 infection in health professionals at a spanish hospital. IJERPH. 2020;17(12):4305.
   Web of Science ®Google Scholar
• Azaña Gómez J, Pérez-Belmonte LM, Rubio-Rivas M, et al. Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: data from the SEMI-COVID-19 registry. Med Clin. 2022;159(10):457–464.
   PubMed Web of Science ®Google Scholar
• Handy A, Banerjee A, Wood AM, et al. Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort. Heart. 2022;108(12):923–931.
   PubMed Web of Science ®Google Scholar
• Louis DW, Kennedy KF, Saad M, et al. Preadmission oral anticoagulation for atrial fibrillation/flutter and death or thrombotic events during COVID-19 admission. Am J Cardiol. 2022;181:38–44.
   PubMed Web of Science ®Google Scholar
• Deitelzweig S, Zhu J, Jiang J, et al. Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19. Curr Med Res Opin. 2022;38(11):1891–1896.
   PubMed Web of Science ®Google Scholar
• Testa S, Paoletti O, Giorgi-Pierfranceschi M, et al. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients. Intern Emerg Med. 2020;15(5):751–753.
   PubMed Web of Science ®Google Scholar
• Vivas D, Roldán V, Esteve-Pastor MA, et al. Recommendations on antithrombotic treatment during the COVID-19 pandemic. Rev Esp Cardiol. 2020;73(9):749–757.
   Web of Science ®Google Scholar
• Cerezo-Manchado JJ, Meca Birlanga O, García de Guadiana Romualdo L, et al. Dabigatran in patients with atrial fibrillation after COVID-19 hospitalization: an update of the ANIBAL protocol. DIC. 2022;11:1–11. 4.
   Google Scholar
• Potere N, Candeloro M, Porreca E, et al. Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone. J Thromb Thrombolysis. 2022;53(2):346–351.
   PubMed Web of Science ®Google Scholar
• Rahimi FS, Afaghi S, Tarki FE, et al. Risk factors, thromboembolic events, and clinical course of new-onset atrial fibrillation among COVID-19 hospitalized patients: a multicenter cross-sectional analysis in Iran. Health Sci Rep. 2022;5(6):e813.
   PubMedGoogle Scholar
• Cutler MJ, May HT, Bair TL, et al. Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19. Int J Cardiol Heart Vasc. 2022;43:101127.
   PubMed Web of Science ®Google Scholar
• Zuin M, Bilato C. Increase in atrial fibrillation-related mortality in the United States during the COVID-19 pandemic. Heart Rhythm. 2022. 2023;20(2):163–164.
   PubMed Web of Science ®Google Scholar
• Rubini-Costa R, Bermúdez-Jiménez F, Rivera-López R, et al. Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection. Med Clin (Engl Ed). 2022;158(12):569–575.
   PubMedGoogle Scholar
• Wilkinson C, Wu J, Searle SD, et al. Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial. BMC Med. 2020;18(1):401.
   PubMed Web of Science ®Google Scholar
• Bistrovic P, Manola S, Papic I, et al. Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis. Am J Emerg Med. 2022;59:182–183.
   PubMed Web of Science ®Google Scholar